3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Suspended
1
Sponsor Class
OTHER_GOV
1
Study Type
Interventional
1
Sponsor
Conditions
Malignant Female Reproductive System Neoplasm
1
Interventions
Heparin
1
Enoxaparin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Suspended
×
Malignant Female Reproductive System Neoplasm
×
Heparin
×
Clear all
NCT01356329
2016-05-13
Lovenox
National Guard Health Affairs
Phase 3
Suspended
150 enrolled